WM — Waste Management, Inc.

Analyst consensus is Buy, with FMP's price target at $244 and recent street targets ranging from $244 to $277, but the tape has been weak: shares are near the lower end of the 52-week range and below all major moving averages. Investors are balancing WM's strong margin execution and free cash flow against softening collection volumes, RNG timing, and leadership transition uncertainty.

Revenue growth is decelerating after the Stericycle-driven step-up: Q2 2026 revenue was up about 4.0% YoY versus roughly 19% YoY in Q2 2025 and 7.1% in Q4 2025. Operating margins have hovered in the 17-19% range, with Q2 2026 at 18.8% versus 18.5% a year earlier, and diluted EPS improved from $1.49 in Q3 2025 to $1.95 in Q2 2026. This looks like a return to mid-single-digit organic growth after an acquisition comp, not a structural decline, with margins and cash conversion actually firming.

At $217.76, WM trades at 30.7x TTM EPS and 3.39x sales, slightly below its 5-year averages of 32.25x earnings and 3.59x sales, so valuation is fair rather than cheap or rich. Forward P/E on next-fiscal-year EPS of $8.11 is about 26.8x. The TTM PEG of 6.3 is misleading due to low trailing earnings growth from acquisition timing; on forward estimates the multiple is more reasonable but still reflects a quality premium for a defensive, pricing-power business.

The stock is pricing in a stable, margin-resilient business but not a major growth acceleration. Q2 showed exactly that: EPS beat by $0.04, but revenue missed slightly and management cut the full-year revenue outlook while raising EBITDA margin guidance. Price is roughly fair for current earnings and cash flow, not discounting a sharp upturn. A move toward higher analyst targets likely needs either volume stabilization or continued margin/FCF upside; failure on either front keeps WM range-bound.

As of 2026-08-27, RSI(14) is 33.8, price is 3.15% below the 20-day, 4.55% below the 50-day, and 3.12% below the 200-day. That is a weak, near-oversold short-term picture inside a roughly $194-248 range, with the stock near the lower third. Momentum is not yet confirming a bottom; a close back above the 20-day or a clear higher low would improve the entry timing.

• Softening collection volumes: WM trimmed its FY2026 volume outlook to about -1%, so pricing and cost control must carry growth.
• Interest rates: with debt-to-equity of 2.35 and long-term debt of $22.3 billion, WM is sensitive to refinancing costs; a lower rate environment would support the multiple.
• Sustainability regulation: recycling, landfill gas, and renewable natural gas projects create a capex pipeline and potential long-term margin upside.
• M&A integration: Stericycle healthcare waste synergies of over $300 million by late 2027 are a tailwind to earnings even with flat organic volumes.
• Inflation and labor/operating costs: WM's contractual pricing power helps offset wage and fuel inflation, but input inflation remains a risk if pricing lags.

• Q3 2026 earnings in late October: the market will look for continued margin expansion and stable pricing against weak volumes.
• CEO transition on January 4, 2027: John Morris taking over raises execution/strategy questions but also offers a potential clarity catalyst.
• RNG and recycling project milestones, which could extend WM's higher-margin sustainability revenue stream.
• Interest rate cuts, which would reduce the cost of WM's large debt load and support its defensive, dividend-paying profile.

• A deeper macro downturn pushing collection volumes down more than the guided -1% would pressure organic revenue and operating leverage.
• Stericycle integration shortfall: below-expected synergies, healthcare waste pricing pressure, or asset writedowns would hit margins.
• High leverage and a current ratio of 0.91 leave limited balance sheet cushion if free cash flow disappoints.
• CEO transition could create strategic drift or raise investor uncertainty about capital allocation priorities.
• Valuation de-rating risk: at roughly 30x trailing earnings, WM has multiple to lose if growth stays sub-4% and margins stop expanding.

WM is a high-quality, defensive compounder with pricing power, improving margins, and strong free cash flow, but it is also a slow-growth, heavily leveraged business trading at a fair full multiple. As of 2026-08-27, the risk/reward is balanced: the stock is near the lower end of its range with solid cash generation, yet there is no obvious catalyst to push it well above the low-$230s without volume stabilizing. This is a hold-type setup for a diversified individual investor rather than a clear bargain.

I applied a 28.5x forward multiple to next-FY consensus EPS of $8.11, a discount to WM's 5-year average trailing P/E of 32.25 to reflect soft volumes, RNG timing, and CEO transition risk while crediting strong margins and FCF. This yields $231, cross-checked by TTM FCF per share of about $8.94 at roughly 25.8x.